Catalent lands 2 new partnerships, including for glioblastoma drug; US drops $153M into pandemic preparedness

Date Published07/15/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Curtana Pharmaceuticals
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2021
Domestically, the work will be done:Outsourced
City reshored to:San Diego
State(s) reshored to:CA
If relevant, work nearshored to:-
Product(s) reshoredCT-179, drug therapy for cancers
What domestic positive factors made reshoring more attractive?Other, import replacement
Find Reshoring Articles